Literature DB >> 22552009

Proteomics-based identification of α-enolase as a potential prognostic marker in cholangiocarcinoma.

Ponlapat Yonglitthipagon1, Chawalit Pairojkul, Vajarabhongsa Bhudhisawasdi, Jason Mulvenna, Alex Loukas, Banchob Sripa.   

Abstract

OBJECTIVES: To investigate the association of expression status of α-enolase (ENO1) and clinicopathological outcomes of CCA patients. DESIGN AND METHODS: Two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS) were used to compare differential expressed protein profiles of four human CCA cell lines and H69, a non-malignant biliary cell line, as a control. Immunohistochemical analysis was carried out in tissue-microarray of human CCA tissues (n=301).
RESULTS: We identified ENO1 in all CCA cell lines but not H69 by proteomics based. About 75% of patients with CCA showed over-expression of ENO1 in hyperplastic bile duct and the tumors compared with that in tumor-adjacent normal tissue counterparts. Moreover, over-expression of ENO1 is significantly associated with poor prognosis and tumor invasion of CCA patients.
CONCLUSIONS: ENO1 may serve as a prognostic marker to monitor the disease progression of these patients.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552009      PMCID: PMC3380142          DOI: 10.1016/j.clinbiochem.2012.04.004

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  34 in total

Review 1.  Opisthorchiasis control in Thailand.

Authors:  P Jongsuksuntigul; T Imsomboon
Journal:  Acta Trop       Date:  2003-11       Impact factor: 3.112

2.  The nucleotide sequence of a Drosophila melanogaster enolase gene.

Authors:  J G Bishop; V G Corces
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

3.  Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.

Authors:  Gee-Chen Chang; Ko-Jiunn Liu; Chia-Ling Hsieh; Tsai-Shu Hu; Suparat Charoenfuprasert; Hsiung-Kun Liu; Kwen-Tay Luh; Li-Han Hsu; Chew-Wen Wu; Chou-Chik Ting; Chih-Yi Chen; Kun-Chieh Chen; Tsung-Ying Yang; Teh-Ying Chou; Wen-Hua Wang; Jacqueline Whang-Peng; Neng-Yao Shih
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

4.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes.

Authors:  B Altenberg; K O Greulich
Journal:  Genomics       Date:  2004-12       Impact factor: 5.736

5.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

Authors:  B H Jiang; F Agani; A Passaniti; G L Semenza
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

6.  Plasminogen/plasmin regulates alpha-enolase expression through the MEK/ERK pathway.

Authors:  Lirlândia P Sousa; Breno M Silva; Bruno S A F Brasil; Sarah V Nogueira; Paulo C P Ferreira; Erna G Kroon; Kanefusa Kato; Cláudio A Bonjardim
Journal:  Biochem Biophys Res Commun       Date:  2005-10-04       Impact factor: 3.575

7.  Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients.

Authors:  Li Zhong; Xuejun Peng; Giovanna E Hidalgo; Dennis E Doherty; Arnold J Stromberg; Edward A Hirschowitz
Journal:  Cancer Detect Prev       Date:  2003

Review 8.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

Review 9.  A review and update on cholangiocarcinoma.

Authors:  Matthew J Olnes; Rodrigo Erlich
Journal:  Oncology       Date:  2004       Impact factor: 2.935

10.  Cloning, expression and sequence homologies of cDNA for human gamma enolase.

Authors:  D Oliva; G Barba; G Barbieri; A Giallongo; S Feo
Journal:  Gene       Date:  1989-07-15       Impact factor: 3.688

View more
  16 in total

1.  Effects of α-enolase (ENO1) over-expression on malignant biological behaviors of AGS cells.

Authors:  Yang-Qi Liu; Zhi-Gang Huang; Ge-Nan Li; Jin-Lin Du; Yang-Ping Ou; Xiang-Ning Zhang; Ting-Ting Chen; Qi-Lian Liang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.

Authors:  Atit Silsirivanit; Kanlayanee Sawanyawisuth; Gregory J Riggins; Chaisiri Wongkham
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-02-12       Impact factor: 7.027

3.  Proteomic characterization of the internalization of Opisthorchis viverrini excretory/secretory products in human cells.

Authors:  Sujittra Chaiyadet; Michael Smout; Thewarach Laha; Banchob Sripa; Alex Loukas; Javier Sotillo
Journal:  Parasitol Int       Date:  2016-02-09       Impact factor: 2.230

Review 4.  Molecular Targets in Biliary Carcinogenesis and Implications for Therapy.

Authors:  Tolutope Oyasiji; Jianliang Zhang; Boris Kuvshinoff; Renuka Iyer; Steven N Hochwald
Journal:  Oncologist       Date:  2015-05-29

5.  FBXW7 negatively regulates ENO1 expression and function in colorectal cancer.

Authors:  Panpan Zhan; Yuli Wang; Shihu Zhao; Chunyan Liu; Yunshan Wang; Mingxin Wen; Jian-Hua Mao; Guangwei Wei; Pengju Zhang
Journal:  Lab Invest       Date:  2015-06-22       Impact factor: 5.662

6.  Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry.

Authors:  Xuede Zhang; Wei Li; Yanli Hou; Zequn Niu; Yujie Zhong; Yuping Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

7.  Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.

Authors:  Qiao-Fen Fu; Yan Liu; Yue Fan; Sheng-Ni Hua; Hong-Ying Qu; Su-Wei Dong; Rui-Lei Li; Meng-Yang Zhao; Yan Zhen; Xiao-Li Yu; Yi-Yu Chen; Rong-Cheng Luo; Rong Li; Li-Bo Li; Xiao-Jie Deng; Wei-Yi Fang; Zhen Liu; Xin Song
Journal:  J Hematol Oncol       Date:  2015-03-08       Impact factor: 17.388

8.  Enolase-1 is a therapeutic target in endometrial carcinoma.

Authors:  Mengyang Zhao; Weiyi Fang; Yan Wang; Suiqun Guo; Luyun Shu; Lijing Wang; YiYu Chen; Qiaofen Fu; Yan Liu; Shengni Hua; Yue Fan; Yiyi Liu; Xiaojie Deng; Rongcheng Luo; Zhong Mei; Qinping Jiang; Zhen Liu
Journal:  Oncotarget       Date:  2015-06-20

Review 9.  An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.

Authors:  Pattaya Seeree; Phorutai Pearngam; Supeecha Kumkate; Tavan Janvilisri
Journal:  Int J Genomics       Date:  2015-09-02       Impact factor: 2.326

10.  Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma.

Authors:  Ye Song; Qisheng Luo; Hao Long; Zheng Hu; Tianshi Que; Xi'an Zhang; Zhiyong Li; Gang Wang; Liu Yi; Zhen Liu; WeiYi Fang; Songtao Qi
Journal:  Mol Cancer       Date:  2014-03-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.